Content 2009


Chekhun V.F.
Cancer stem cells
Vol. 31     N1. - C.2.

Golias Ch., Iliadis I., Peschos D., Charalabopoulos K.
Amplification and co-regulators of androgen receptor gene in prostate cancer
Vol. 31     N1. - C.3.

Filip A., Clichici S., Daicoviciu D., Adriana M., Postescu I.D., Perde-Schrepler M., Olteanu D.
Photochemoprevention of cutaneous neoplasia through natural products
Vol. 31     N1. - C.9.

Pushkarev V.M., Starenki D.V., Saenko V.A., Yamashita S., Kovzun O.I., Popadiuk I.D., Pushkarev V.V., Tronko M.D.
Effects of low and high concentrations of antitumour drug Taxol in anaplastic thyroid cancer cells
Vol. 31     N1. - C.16.

Sen A., Chaudhuri T.K.
Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent
Vol. 31     N1. - C.22.

Yan L.L., Zhang Y.J., Gao W.Y., Man S.L., Wang Y.
In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis
Vol. 31     N1. - C.27.

Kaznica A., Drewa T., Lakomska I., Ryta-Stamirowsk P., Debski R., Styczynski J., Drewa G., Szlyk E.
Influence of two Pt(IV) complexes on viability, apoptosis and cell cycle of B16 mouse melanoma tumors
Vol. 31     N1. - C.33.

Gryshkova V., Goncharuk I., Gurtovyy V., Khozhayenko Yu., Nespryadko S., Vorobjova L., Usenko V., Gout I., Filonenko V., Kiyamova R.
The study of phosphate transporter NaPi2b expression in different histological types of epithelial ovarian cancer
Vol. 31     N1. - C.37.

Guo B., Luo C., Xun C., Xie J., Wu X., Pu J.
Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR
Vol. 31     N1. - C.43.

Buchynska L.G., Iurchenko N.P., Grinkevych V.M., Nesina I.P., Chekhun S.V., Svintsitsky V.S.
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
Vol. 31     N1. - C.48.

Krzystek-Korpac M., Matusiewicz M., Diakowska D., Grabowski K., Blachut K., Kustrzeba-Wojci I., Gamian A.
Even a mild anemia is related to tumor aggressiveness mediated by angiogenic factors
Vol. 31     N1. - C.52.

Sliwinski T., Markiewicz L., Rusin P., Pietruszewska W., Olszewski J., Morawiec-Sztand A., Mlynarski W., Majsterek I.
Polymorphisms of the DNA base excision repair geneMUTYH in head and neck cancer
Vol. 31     N1. - C.57.

Mauri D., Panou C., Valachis A., Kamposioras K., Tsali L.
Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
Vol. 31     N1. - C.60.

Kaledin V.I., llnitskaya S.I., Nikolin V.P., Popova N.A., Smagin D.A., Kudryavtseva N.N.
Limiting effect of diazepam on lewis Lung carcinoma metastasis in anxious male mice
Vol. 31     N1. - C.62.


Chekhun V.F.
Metastasis - quo vadis?
Vol. 31     N2. - C.66.

Yenamandra S.P., Klein G., Kashuba E.
Nuclear receptors and their role in Epstein - Barr virus induced B cell transformation
Vol. 31     N2. - C.67.

Demydenko D., Berest I.
Expression of galectin-1 in malignant tumors
Vol. 31     N2. - C.74.

Osinsky S., Zavelevich M., Vaupel P.
Tumor hypoxia and malignant progression
Vol. 31     N2. - C.80.

Lukyanova N.Yu, Rusetskya N.V., Tregubova N.A., Chekhun V.F.
Molecular profile and cell cycle in MCF-7?cells resistant to cisplatin and doxorubicin
Vol. 31     N2. - C.87.

Yenamandra S.P., Lundin V. Arula A., Yurchenko M., Pettersson S., Klein G., Kashuba E.
Expression profile of nuclear receptors upon Epstein - Barr virus induced B cell transformation
Vol. 31     N2. - C.92.

Magorivska I., Bilyy R., Shalay O., Loginsky V., Kit Y., Stoika R.
Blood serum immunoglobulins of patients with multiple myeloma are capable of hydrolysing histone H1
Vol. 31     N2. - C.97.

Xu X., Yuan G., Liu W., Zhang Y., Chen W.
Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance
Vol. 31     N2. - C.102.

Giesel F.L., Mehndiratta A., Locklin J., McAuliffe M.J., White S., Choyke P.L., Knopp M.V., Wood B.J., Haberkorn U., von Tengg-Kobli H.
Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA
Vol. 31     N2. - C.106.

Horacek J.M., Jakl M., Horackova J., Pudil R., Jebavy L., Maly J.
Assessment of anthracycline-induced cardiotoxicity with electrocardiography
Vol. 31     N2. - C.115.

Pai R.B., Lalitha R.M., Pai S.B., Kumaraswamy S.V., Lalitha N., Bhargava M.K.
Analysis of in vitro and in vivo sensitivity of oral cancer cells to methotrexate
Vol. 31     N2. - C.118.

Horacek J.M., Jebavy L., Jakl M., Zak P., Mericka P., Maly J.
Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients - impact of cryopreservation with dimethylsulfoxide
Vol. 31     N2. - C.121.

Chekhun V.F., Zhylchuk V.E., Lukyanova N.Yu, Vorontsova A.L., Kudryavets Yu.I
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
Vol. 31     N2. - C.123.


Chekhun V.F.
Stroma - regulator of cancer cell progression
Vol. 31     N3. - C.126.

Shlyakhovenko V.A.
Ribonucleases in tumor growth
Vol. 31     N3. - C.127.

Shabelnik M.Yu, Kostyuk O.V., Merentsev S.V., Tarasova T.O., Sidorenko S.P.
Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2
Vol. 31     N3. - C.134.

Rusetskaya N.V., Lukyanova N.Yu, Chekhun V.F.
Molecular profile and cell cycle in MCF-7 and MCF?7/Dox cells exposed to conventional and liposomal forms of doxorubicin
Vol. 31     N3. - C.140.

Inamura Y., Koide T., Kojima T., Nagata H., Ito N., Suzumura K., Hashimoto Y.
In VIVO anti-tumor activities of gelatin
Vol. 31     N3. - C.144.

Roomi M.W., Bhanap B.A., Roomi N.W., Rath M., Niedzwiecki A.
Antineoplastic effects of nutrient mixture on Raji and Jurkat t cells: the two highly aggressive non hodgkin's lymphoma cell lines
Vol. 31     N3. - C.149.

Saitoh Y., Yoshimura Y., Nakano K., Miwa N.
Platinum nanocolloid-supplemented hydrogendissolved water inhibits growth of human tongue carcinoma cells preferentially over normal cells
Vol. 31     N3. - C.156.

Chekhun V.F., Todor I.N., Lukyanova N.Yu, Shpyleva S.I., Naleskina L.A., Khaetsky I.K., Kulik G.I.
The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs
Vol. 31     N3. - C.163.

Rusin P., Markiewicz L., Olszewski J., Morawiec-Sztand A., Kowalski M., Przybylowska K., Kaczmarczyk D., Kusmierczyk K., Majsterek I.
DNA double strand breaks repair and apoptosis induction in peripheral blood lymphocytes of head and neck cancer patients
Vol. 31     N3. - C.168.

Goncharuk I.V., Vorobjova L.I., Lukyanova N.Y., Chekhun V.F.
Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival
Vol. 31     N3. - C.179.

Bazas V.M., Lukyanova N.Yu, Lisovenko G.S., Rozumiy D.O., Potebnya G.P.
Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue
Vol. 31     N3. - C.182.

Fujimoto T., Finnegan M.
The effect of gadodiamide on cancer cell lines
Vol. 31     N3. - C.185.


Chekhun V.F.
INFLAMMATION AND CANCER
Vol. 31     N4. - C.190.

Editors
DEVOTION TO SCIENCE IDEALS (To 110th birthday anniversary of academician R.E. Kavetsky)
Vol. 31     N4. - C.191.

Tarkan-Arguden Y.
ARE MONOSOMIES UNDERESTIMATED WHILE ANALYZING CANCER CELLS?
Vol. 31     N4. - C.194.

Saczko J., Skrzypek W., Chwilkowska A., Choromanska A., Pola  A., Gamian A., Kulbacka J.
PHOTO-OXIDATIVE ACTION IN CERVIX CARCINOMA CELLS INDUCED BY HPD - MEDIATED PHOTODYNAMIC THERAPY
Vol. 31     N4. - C.195.

Baldea I., Mocan T., Cosgarea R.
THE ROLE OF ULTRAVIOLET RADIATION AND TYROSINE STIMULATED MELANOGENESIS IN THE INDUCTION OF OXIDATIVE STRESS ALTERATIONS IN FAIR SKIN MELANOCYTES
Vol. 31     N4. - C.200.

Kojima T., Hashimoto Y., Inamura Y., Koide T., Nagata H., Ito N., Suzumura K.
SERUM FACTORS THAT SUPPRESS CYTOTOXIC EFFECT OF METHOTREXATE
Vol. 31     N4. - C.209.

Roomi M.W., Kalinovsky T., Niedzwiecki A., Rath M.
ANTIANGIOGENIC PROPERTIES OF A NUTRIENT MIXTURE IN A MODEL OF HEMANGIOMA
Vol. 31     N4. - C.214.

Varol U., Karaca B., Tunali D., Degirmenci M., Cirak Y., Purcu D.U., Uzunoglu S., Sezgin C., Karabulut B., Sanli U.A, Uslu R.
THE EFFECT OF RACEMIC GOSSYPOL AND AT-101 ON ANGIOGENIC PROFILE OF OVCAR-3 CELLS: A PRELIMINARY MOLECULAR FRAMEWORK FOR GOSSYPOL ENANTIOMERS
Vol. 31     N4. - C.220.

Potebnya G.P., Voeykova I.M., Lisovenko G.S., Cheremshenko N.L., Todor I.M., Yudina O.Yu, Kovtonyuk O.V., Chekhun V.F.
ANTITUMOR AND ANTIMETASTATIC ACTIVITIES OF VACCINE PREPARED FROM CISPLATIN-RESISTANT LEWIS LUNG CARCINOMA
Vol. 31     N4. - C.226.

Timovska Yu.O, Pivnyuk V.M., Oliynichenko G.P., Anikushko M.F., Zachartseva L.M., Chekhun V.F.
RELATION BETWEEN PATHOMORPHOLOGICAL RESPONSE IN TUMORS AFTER NEOADJUVANT CHEMOTHERAPY AND CLINICO-MORPHOLOGICAL AND MOLECULAR PROGNOSTIC FACTORS IN PATIENTS WITH BREAST CANCER
Vol. 31     N4. - C.231.

Lozynska M.
THE PROGNOSTIC VALUE OF CYTOGENETIC MARKERS FOR EARLY DIAGNOSIS OF COLORECTAL CANCER
Vol. 31     N4. - C.237.

Berezhnaya N.M., Belova O.B., Vinnichuk Yu.D, Tarutinov V.I.
EXPRESSION OF E-CADHERIN IN DRUG RESISTANT HUMAN BREAST CANCER CELLS AND THEIR SENSITIVITY TO LYMPHOKINE-ACTIVATED LYMPHOCYTES ACTION
Vol. 31     N4. - C.242.

Iemelynova A.A., Grygorenko V.M., Cheremuha S.V., Romanenko A.M.
CORRELATION BETWEEN HISTOLOGICAL TYPE AND IMMUNOHISTOCHEMICAL PROFILE OF PROSTATE CANCER AND GLEASON SCALE GRADATION
Vol. 31     N4. - C.246.

Krupa R., Sliwinski T., Morawiec Z., Pawlowska E., Zadrozny M., Blasiak J.
ASSOCIATION BETWEEN POLYMORPHISMS OF THE BRCA2 GENE AND CLINICAL PARAMETERS IN BREAST CANCER
Vol. 31     N4. - C.250.


<< to the beginning of the text